Related Experiment Video
Updated: May 3, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children
Zhao Yang1, Colin J McMahon, Liana R Smith
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Insights
Lysosome-associated protein-2 (LAMP-2) gene mutations are found in 4% of pediatric hypertrophic cardiomyopathy (HCM) patients, indicating Danon disease is often overlooked in children with HCM, skeletal myopathy, or Wolff-Parkinson-White syndrome.
Area of Science:
- Genetics
- Cardiology
- Rare Diseases
Background:
- Hypertrophic cardiomyopathy (HCM) and left ventricular hypertrophy can co-occur with skeletal myopathy and Wolff-Parkinson-White (WPW) syndrome.
- Mutations in the lysosome-associated protein-2 (LAMP-2) gene are linked to these combined conditions, suggesting Danon disease.
- This study aimed to determine the prevalence of LAMP2 mutations in pediatric HCM patients.
Observation:
- Genomic DNA from 50 pediatric HCM patients was analyzed for LAMP2 mutations.
- Nonsense mutations in LAMP2 were identified in 4% (2 out of 50) of the probands.
- Affected families displayed varied phenotypes, including progression from HCM to dilated cardiomyopathy (DCM), skeletal myopathy, and WPW syndrome.
Findings:
- LAMP2 mutations were detected in 4% of the unselected pediatric HCM cohort.
- Immunohistochemical staining confirmed the absence of LAMP-2 in skeletal and cardiac muscle tissues of affected individuals.
- Phenotypic variability was observed, with carriers exhibiting different clinical presentations.
Implications:
- LAMP2 mutations represent a notable cause of HCM in children, particularly when accompanied by skeletal myopathy or WPW syndrome.
- Danon disease may be underdiagnosed within the pediatric cardiology community.
- Genetic screening for LAMP2 mutations is recommended for pediatric HCM patients with associated symptoms.
Background:
Some patients with hypertrophic cardiomyopathy (HCM) or left ventricular hypertrophy also present with skeletal myopathy and Wolff-Parkinson-White (WPW) syndrome; mutations in the gene encoding the lysosome-associated protein-2 (LAMP-2) have been identified in these patients, suggesting that some of these patients have Danon disease. In this study we investigated the frequency of LAMP2 mutations in an unselected pediatric HCM population.
Methods And Results:
LAMP2 was amplified from genomic DNA isolated from peripheral lymphocytes of 50 patients diagnosed with HCM and analyzed by direct DNA sequencing. In 2 of the 50 probands (4%), nonsense mutations were identified. In 1 family the proband initially presented with HCM as a teenager, which progressed to dilated cardiomyopathy (DCM) and heart failure. Skeletal myopathy and WPW were also noted. The teenage sister of the proband is a carrier of the same LAMP2 mutation and has HCM without skeletal myopathy or WPW. The other proband presented with HCM, WPW, and skeletal myopathy as a teenager, whereas his carrier mother developed DCM during her 40s. Skeletal and cardiac muscle sections revealed the absence of LAMP-2 on immunohistochemical staining.
Conclusions:
LAMP2 mutations may account for a significant proportion of cases of HCM in children, especially when skeletal myopathy and/or WPW is present, suggesting that Danon disease is an underrecognized entity in the pediatric cardiology community.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aneurysm I: Introduction
Diphtheria

